ArticleBMJ open2026
Mortality patterns in multimorbid populations: cross-sectional population-wide analysis of Czech national registry data, 2014-2023.
Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe aim is to (i) examine the evolution of (multi-)morbidity in Czechia, (ii) analyse changes in mortality by (multi-)morbidity between 2014 and 2023 and (iii) analyse factors driving mortality change in these subpopulations, using national health registry data, which is unique among countries of the former Eastern Bloc.
designCross-sectional population-wide analysis.
settingCzechia.
participantsAdult population aged 30 and above (n~7.5 million). OUTCOME MEASURES: 1-year period prevalence proportion by age, age-specific and disease-specific occurrence-exposure mortality rates and their coefficient of variation, contributions of age composition, multimorbidity composition and mortality rates to mortality change.
resultsBetween 2014 and 2023, the prevalence of no or single diseases remained stable at 55%, while complex multimorbidity patterns (3+ diseases) decreased, especially in the 60+ group (from 20% to 16%). Despite additional diagnoses being associated with elevated mortality, especially for those with diabetes and chronic obstructive pulmonary disease (COPD), mortality risks homogenised across (multi)morbid groups, and overall mortality declined (9 pp in neoplasm and COPD, 7 pp in cerebrovascular diseases and 3 pp in diabetes). This decline was primarily due to shifts in multimorbidity composition; without this, mortality in groups with cerebrovascular diseases, diabetes and COPD would have risen.
conclusionThe change in mortality over the past decade in Czechia among people with chronic diseases is mainly driven by shifts in multimorbidity composition, rather than pure effects of decline in mortality, contributing to diverging patterns of change between individuals with and without chronic conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.